Protein tyrosine phosphatase 1B (PTP1B), the first characterized protein tyrosine phosphatase (PTPases), has become a new target for the treatment of T2DM because of its involvement in the insulin signaling cascade as a major negative regulator [2]. The gene discussed is INS; the disease is type 2 diabetes mellitus.